Virus News and Research

Latest Virus News and Research

Study shows why social media users are more hesitant about getting vaccinated

New research has found that the most reliable indicators of willingness to be vaccinated against SARS-CoV-2, the virus that causes COVID-19, are rejection of conspiracy suspicions about COVID-19 and a positive attitude towards vaccines in general.

15 Apr 2021

People who trust TV and Facebook for accurate news about COVID-19 are less knowledgeable

People who trust television and Facebook to provide them with accurate news about the coronavirus pandemic are less knowledgeable about COVID-19, according to a new study, which assessed people's knowledge of the virus in the earliest stages of the pandemic.

15 Apr 2021

More than half of COVID-19 patients report persistent symptoms 12-months after infection

In a new study, appearing on the pre-print server medRxiv*, researchers at the University of Trieste and Istituto Auxologico Italiano IRCCS in Italy report that more than half of patients with previous mild-to-moderate symptomatic COVID-19 complained of the persistence of at least one symptom 12-months after the onset of the illness.

15 Apr 2021

Intestinal worm infections can make African women more vulnerable to sexually-transmitted viral infections

Intestinal worm infections can leave women in sub-Saharan Africa more vulnerable to sexually-transmitted viral infections, a new study reveals.

15 Apr 2021

New mathematical model predicts the spread of COVID-19

Scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory and the University of Illinois Urbana-Champaign (UIUC) have developed a new mathematical model for predicting how COVID-19 spreads.

15 Apr 2021

Wearing masks and social distancing can contain the spread of COVID-19 virus

Studies show wearing masks and social distancing can contain the spread of the COVID-19 virus, but their combined effectiveness was not precisely known.

15 Apr 2021

Population-based study shows the persistence of neutralizing antibodies against coronavirus

It is an open question to what extent protection against reinfection persists after overcoming a SARS-CoV-2 infection.

15 Apr 2021

New research could help solve major challenge in the deployment of COVID-19 vaccines

New research by University of Texas at Dallas scientists could help solve a major challenge in the deployment of certain COVID-19 vaccines worldwide -- the need for the vaccines to be kept at below-freezing temperatures during transport and storage.

15 Apr 2021

New device can be used to disinfect surfaces without special training

The COVID-19 pandemic has cast a harsh light on the urgent need for quick and easy techniques to sanitize and disinfect everyday high-touch objects such as doorknobs, pens, pencils, and personal protective gear worn to keep infections from spreading.

15 Apr 2021

COVID-19 deadlier than cars for over 40s, study finds

The study, which appeared on the pre-print server medRxiv, presented mortality rates and case-fatality rates for COVID-19 compared with other historic leading causes of death in the United States.

15 Apr 2021

NIAID establishes a network of research sites to study influenza outbreaks

he National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has established a network of research sites to study the natural history, transmission and pathogenesis of influenza and provide an international research infrastructure to address influenza outbreaks.

15 Apr 2021

Speed of vaccination is key to reducing COVID-19 spread, says study

Mathematical modeling of the effects of vaccine efficacy and the speed of vaccination show that a lower efficacy vaccine may curb disease transmission similar to that of a higher efficacy vaccine if the speed of immunization is high.

15 Apr 2021

Ebola virus's key protein uses molecular triggers in the human cell to change shape

The human genome contains the instructions to make tens of thousands of proteins. Each protein folds into a precise shape - and biologists are taught that defined shape dictates the protein's destined function.

15 Apr 2021

SARS-CoV-2 variants are widely spread across the Houston metropolitan area

In late 2020, several concerning SARS-CoV-2 variants emerged globally. They are believed to be more easily transmissible, and there is concern that some may reduce the effectiveness of antibody treatments and vaccines.

14 Apr 2021

Updated Moderna vaccines neutralize South African SARS-CoV-2 variant in mice

Researchers in the United States have conducted a pre-clinical study demonstrating the efficacy of two updated versions of the Moderna mRNA-1273 vaccine against variants of severe acute respiratory syndrome coronavirus 2 – the agent that causes coronavirus disease 2019 (COVID-19).

14 Apr 2021

Study sheds light on reduced neutralization of SARS-CoV-2 variants of concern

Researchers in the United States have predicted the binding epitopes of uncharacterized neutralizing antibodies that target the receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.

14 Apr 2021

SARS-CoV-2 mutations impact T-cell recognition of virus

A new research paper posted to the bioRxiv preprint server deals with the impact of these mutations on adaptive cellular immunity.

14 Apr 2021

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

As newer vaccines are being developed to combat the ongoing pandemic of coronavirus disease 2019 (COVID-19), targeting the pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv server describes a new subunit nanovaccine that appears to have robust immunogenicity and neutralizing activity.

14 Apr 2021

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

A new research paper posted to the medRxiv* preprint server describes the changes in genomic sequence observed during the course of infection in a patient on the drug tacrolimus, along with steroids, both potent immunosuppressants, and who also received convalescent plasma treatment. These mutations were observed to occur within three weeks from infection.

14 Apr 2021

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

The study, published in The Lancet, demonstrates that there is no evidence of a link between severe illness and death and lineage when comparing the B.1.1.7 lineage and other variants.

14 Apr 2021

Virus News and Research

Latest Virus News and Research

Study shows why social media users are more hesitant about getting vaccinated

People who trust TV and Facebook for accurate news about COVID-19 are less knowledgeable

More than half of COVID-19 patients report persistent symptoms 12-months after infection

Intestinal worm infections can make African women more vulnerable to sexually-transmitted viral infections

New mathematical model predicts the spread of COVID-19

Wearing masks and social distancing can contain the spread of COVID-19 virus

Population-based study shows the persistence of neutralizing antibodies against coronavirus

New research could help solve major challenge in the deployment of COVID-19 vaccines

New device can be used to disinfect surfaces without special training

COVID-19 deadlier than cars for over 40s, study finds

NIAID establishes a network of research sites to study influenza outbreaks

Speed of vaccination is key to reducing COVID-19 spread, says study

Ebola virus's key protein uses molecular triggers in the human cell to change shape

SARS-CoV-2 variants are widely spread across the Houston metropolitan area

Updated Moderna vaccines neutralize South African SARS-CoV-2 variant in mice

Study sheds light on reduced neutralization of SARS-CoV-2 variants of concern

SARS-CoV-2 mutations impact T-cell recognition of virus

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Virus News and Research

Latest Virus News and Research

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Newsletters you may be interested in